Status unknownNCT01997528Updated Nov 28, 2013

Gas Transfer on ILA-Activve

An interventional study of Change of blood flow or sweep gas flow ( ILA Activve) in Hypercapnia, sponsored by Medical University of Vienna. Status unknown at 1 site in Austria. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2013-11-28.

Sponsored by Medical University of Vienna · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2013), so the status shown — last known as Recruiting — may be out of date.

Phase: Not applicable
Study type: Interventional
Enrollment: 10
Allocation: Not applicable
Ages: 18 Years to 89 Years
Sex: All

Study summary

Oxygenatuion and decarboxylation during different settings (steps of blood flow and sweep gas flow) of extracorporeal gas exchange by ILA Activve using a jugular 22French double lumen cannula are measured.

Conditions studied

Hypercapnia

Browse trials for

Hypercapnia 191

In context

Hypercapnia

191 studies on the registry are indexed under Hypercapnia; 36 are open to participants now.

This study's planned enrollment of 10 is below the median of 48 across 144 interventional studies indexed under Hypercapnia.

Browse Hypercapnia studies →

Lead sponsor

Medical University of Vienna is the lead sponsor of 1,105 studies on the registry; 182 are open to participants now.

Browse Medical University of Vienna studies →

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 18 Years to 89 Years
Sexes eligible: All
Accepts healthy volunteers: No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Patient on ILA Activve
Controlled mechanical ventilation
No spontaneous breathing

Exclusion criteria

Exclusion Criteria:

- Pregnancy

Study design

Phase: Not applicable
Primary purpose: Treatment
Allocation: Not applicable
Intervention model: Single group
Masking: None (open label)
Enrollment: 10 participants (estimated)

Study arms

Experimental
Extracorporeal CO2 elimination by ILA Activve(R)
Device: Change of blood flow or sweep gas flow ( ILA Activve)

Interventions

DeviceChange of blood flow or sweep gas flow ( ILA Activve)

What researchers measure

Primary outcomes

Blood gas analysis
Time frame: Changes after every 15 min. of each setting (13 settings leading to 195 min. altogether)

Study locations

1 of 1 sites recruiting

Dept. of Medicine I, ICU, General Hospital of Vienna
Vienna, State of Vienna 1090, Austria
- Thomas Staudinger, MD · Contact · thomas.staudinger@meduniwien.ac.at · +43140400
- Thomas Staudinger, MD · Principal investigator
Recruiting

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Nov 28, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT01997528
Lead sponsor: Medical University of Vienna
Responsible party: Thomas Staudinger (Ao. Univ.-Prof. Dr., Medical University of Vienna) — Principal investigator
First posted: Nov 28, 2013
Start date: Nov 2013
Primary completion: Nov 2014 (estimated)
Last update: Nov 28, 2013

Study contacts

Thomas Staudinger, MD

principal investigator · Medical University of Vienna

Oversight

Data monitoring committee: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Hypercapnia →

Other studies from this sponsor

Medical University of Vienna →

Start the discussion